SCOTUS hears arguments on birthright citizenship case, here’s what to know

SCOTUS hears arguments on birthright citizenship case, here’s what to know

The Supreme Court is taking up one of the term’s most consequential cases, President Donald Trump’s executive order on birthright citizenship, declaring that children born to parents who are in the United States illegally or temporarily are not American citizens, and he was in the courtroom on Wednesday for the arguments. The justices will hear Trump’s appeal of a lower-court ruling from New Hampshire that struck down the citizenship restrictions, one of several courts that have blocked them. They have not taken effect anywhere in the country. Joining us for live analysis this morning is Adam Winkler, professor of law at UCLA.

With files from the Associated Press.

Could the economy be heading for a cliff?

While the war with Iran has spurred a new bout of uncertainty for consumers, it’s just the latest challenge our overall economy is facing. Surging gas and energy prices due to the war’s impact on oil production is only adding to concerns in another sector of the economy: private credit. Private credit refers to the lending of money by individual institutions, rather than banks. Institutions like private equity firms, asset managers, and hedge funds looking to invest money create these loans without the oversight and regulations that banks are required to adhere to in order to mitigate risk. The upshot for these institutions is that they receive higher interest payments, and their borrowers get more flexible funding. But as private credit has surged in popularity, the murkiness of the private credit market has some worrying that another 2008 could be on our hands. To explain why that may be the case, we are joined today by Richard Bookstaber. He has been a chief risk officer at major banks, including Morgan Stanley, and worked at the US Treasury in the aftermath of the 2008 crisis.

Food companies target weight-loss drug users with ‘GLP-1 Friendly’ products

Meals and snacks with “GLP-1 Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity drugs like Wegovy and Zepbound to lose weight. But the labels aren’t regulated by the U.S. Food and Drug Administration, unlike the popular medications themselves. Experts say people taking GLP-1 drugs need to read ingredient lists and talk to medical providers about what nutrients they need – and don’t need. Today on AirTalk, we are joined by Dr. Priya Jaisinghani, Clinical Assistant Professor at NYU’s School of Medicine, and Marie Bragg, Associate Professor of Population Health at NYU’s School of Medicine. We also want to hear from you! Have you latched on to a food product marketed as “healthy?” Give us a call at 866-893-5722 or email us at atcomments@laist.com.

With files from the Associated Press.

Is a lack of male therapists something to be concerned about?

The mental health space has seen a drastic gender shift over the past few decades, with women now significantly outnumbering men in the space. The field of psychology becoming more female-dominated has led to strides in one area of women’s health research, which in other major areas has been historically underlooked. But at the same time, it has created a dearth of male therapists. While professionals say a therapist's gender rarely determines mental health outcomes, there is data to suggest that some men do prefer their therapists to be of the same gender. Men and women tend to also have different mental health needs.With men increasingly open to going to therapy, is a lack of male therapists something to be concerned about? Wall Street Journal writer at large Pamela Paul took up that question in her recent piece, What Will Happen When All the Male Therapists Are Gone?, and she joins AirTalk this morning to discuss.